1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
645D984845C0AB9B785257EC80068CB09
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-best-practices-globalizing-msl-field-based-medical-specialist-programs-structure-operating-models?opendocument
18
19opendocument
2035.175.120.174
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Best Practices in Globalizing MSL & Field-Based Medical Specialist Programs: Structure and Operating Models

ID: 5383


Features:

17 Info Graphics

12 Data Graphics

128 Metrics

6 Narratives


Pages/Slides: 38


Published: 2015


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Best Practices in Globalizing MSL & Field-Based Medical Specialist Programs: Structure & Operating Models"

STUDY OVERVIEW


Biopharmaceutical organizations are increasingly adopting global MSL & Field-Based Medical Specialist (FBMS) programs to achieve corporate goals within regional markets. However, medical affairs leaders often face difficulties in effective global deployment of MSLs and other FBMS.


Best Practices, LLC undertook a benchmarking study to assist medical affairs leaders in achieving functional excellence in MSL globalization. The study examines the structure and operating models utilized to drive success in globalizing field medical teams. It includes benchmarks and insights around organizational structure, leadership and operating models.

This study will allow medical affairs leaders to compare their company's structure and operating models for global field based medical teams with other peer organizations.

KEY TOPICS

  • Organizational Structure & Leadership
  • Operating Models
  • Benchmark Participant Demographics

SAMPLE KEY METRICS

  • Job Title of Direct Manager of MSL/FBMS Function
  • Functional Area MSL/FBMS Leader Reports To
  • Reporting Level of MSL Leaders
  • Current Operating Model
  • Assignment of MSLs Across the Organization
  • Levels with Primary Responsibility for Key Activities
  • Most Important Leadership Qualifications
  • Qualifications of Current MSL/FBMS Leader
  • How MSL/FBMS Teams are Coordinated & Managed Across Organizations
  • Strengths & Weaknesses of Various Operating Models

SAMPLE KEY FINDING

  • MSL Activities Management: The Country/Regional level most often holds primary responsibility for key MSL activities, including administrative support, communicating insights, executing tactics, administering budget, and training MSLs. The Global/Corporate level holds joint responsibility for up to 45% of activities (setting strategy), but rarely hold the primary responsibility.

METHODOLOGY


Thirty-eight leaders of Medical Science Liaison (MSL) and Field-Based Medical Specialist (FBMS) functions at 31 different pharmaceutical, biotech, and medical device companies participated in this study. Results include more than one response from seven companies, where survey participants represented separate MSL organizations.

Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Chemical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; Reliance Life Sciences; Alkermes; Almirall; AstraZeneca; BARD; Baxalta; Baxter Healthcare; Bayer; Biogen; Boehringer Ingelheim; Eisai; Genentech; Janssen; LEO Pharma; Lundbeck; Medivation; Medtronic; Merck; Novartis; Novo Nordisk; Pfizer; Pierre Fabre Medicament; ProStrakan; Roche; Sanofi; Santen; Sunovion; Teva Pharmaceutical Industries Ltd; The Medicines Company; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.